← Back to Clinical Trials
Recruiting NCT02526095

NCT02526095 The French EsoGastricTumours Data Base

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02526095
Status Recruiting
Phase
Sponsor University Hospital, Lille
Condition Esophageal Disease
Study Type OBSERVATIONAL
Enrollment 15,000 participants
Start Date 2014-06
Primary Completion 2027-05

Trial Parameters

Condition Esophageal Disease
Sponsor University Hospital, Lille
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15,000
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2014-06
Completion 2027-05

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.

Eligibility Criteria

Inclusion Criteria: Patient with * esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged. * Naive treatment for this cancer, * Naive treatment for this cancer , failing that received neoadjuvant treatment , * Male or female ≥ 18 years. * social protection scheme . * sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information. Exclusion Criteria: Male or female aged ( e) under 18 years. * Private person of liberty or under supervision (including guardianship ) . * People who do not speak French. * Major Nobody unable to consent . * Patient FREGAT already included in the base. * Patient Refusal .

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology